Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,255 | -22,727 | -10,276 | -6,856 | -2,640 |
| Depreciation Amortization | -720 | -1,569 | -1,848 | -633 | -792 |
| Income taxes - deferred | N/A | 831 | N/A | N/A | N/A |
| Accounts receivable | 203 | 592 | 425 | 220 | 474 |
| Other Working Capital | 761 | 604 | 254 | 264 | 1,126 |
| Other Operating Activity | -50 | 8,589 | 1,189 | 694 | 371 |
| Operating Cash Flow | $-4,061 | $-13,680 | $-10,256 | $-6,311 | $-1,461 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -11 | -57 | -48 | -6 |
| Other Investing Activity | 0 | -1 | 4 | 0 | 0 |
| Investing Cash Flow | $-2 | $-12 | $-53 | $-48 | $-6 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -38 | -118 | -101 | -68 | -34 |
| Financing Cash Flow | $-38 | $-118 | $-101 | $-68 | $-34 |
| Exchange Rate Effect | 50 | -879 | -1,074 | -716 | -203 |
| Beginning Cash Position | 50,611 | 65,300 | 65,300 | 65,300 | 65,300 |
| End Cash Position | 46,560 | 50,611 | 53,816 | 58,157 | 63,596 |
| Net Cash Flow | $-4,051 | $-14,689 | $-11,484 | $-7,143 | $-1,704 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,061 | -13,680 | -10,256 | -6,311 | -1,461 |
| Capital Expenditure | -2 | -11 | -57 | -48 | -6 |
| Free Cash Flow | -4,063 | -13,691 | -10,313 | -6,359 | -1,467 |